NFKB1 and Cancer: Friend or Foe?
Current evidence strongly suggests that aberrant activation of the NF-κB signalling pathway is associated with carcinogenesis. A number of key cellular processes are governed by the effectors of this pathway, including immune responses and apoptosis, both crucial in the development of canc...
Main Authors: | Julia Concetti, Caroline L. Wilson |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-09-01
|
Series: | Cells |
Subjects: | |
Online Access: | http://www.mdpi.com/2073-4409/7/9/133 |
Similar Items
-
Maturation of the Acute Hepatic TLR4/NF-κB Mediated Innate Immune Response Is p65 Dependent in Mice
by: Miguel A. Zarate, et al.
Published: (2020-08-01) -
Case Report: A Novel Mutation in NFKB1 Associated With Pyoderma Gangrenosum
by: Ran Fang, et al.
Published: (2021-08-01) -
Republished: Sulphur alters NFκB-p300 cross-talk in favour of p53-p300 to induce apoptosis in non-small cell lung carcinoma
by: Shilpi Saha, et al.
Published: (2015-01-01) -
A Pathogenic Missense Variant in NFKB1 Causes Common Variable Immunodeficiency Due to Detrimental Protein Damage
by: Manfred Fliegauf, et al.
Published: (2021-04-01) -
Regulation of the Adaptive Immune Response by the IκB Family Protein Bcl-3
by: Felicity D. Herrington, et al.
Published: (2016-03-01)